Standout Papers

Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment 2021 2026 2022 2024116
  1. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment (2021)
    Thomas Stöhr, Pieter Colin et al. British Journal of Anaesthesia

Immediate Impact

2 from Science/Nature 53 standout
Sub-graph 1 of 24

Citing Papers

Targeted protein degradation: from mechanisms to clinic
2024 Standout
SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
2022 Standout
2 intermediate papers

Works of Joachim Ossig being referenced

Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes
2016
Enantioselective inhibition of TNF-? release by thalidomide and thalidomide-analogues
1996

Author Peers

Author Last Decade Papers Cites
Joachim Ossig 318 122 57 140 140 14 695
Greg Plummer 455 98 53 200 44 9 806
J. C. Levron 158 27 75 126 32 35 614
U Kersten 354 76 116 158 20 37 577
Klaas P. Zuideveld 100 71 57 33 24 19 783
I. James 80 45 12 156 32 23 601
Randal L. Batenhorst 446 100 34 291 8 22 676
Jane Blood 177 81 27 153 7 24 759
J. R. Fletcher 44 55 14 139 34 46 739
Pyry A. J. Välitalo 174 35 80 108 10 33 838
Jean‐Claude Levron 223 33 15 222 7 19 593

All Works

Loading papers...

Rankless by CCL
2026